Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines

References

• Andrieux K, Forte L, Lesieur S, et al. (2009). Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt. Eur J Pharm Biopharm 71:346–55
   PubMed Web of Science ®Google Scholar
• Aramaki Y, Tomizawa H, Hara T, et al. (1993). Stability of liposomes in vitro and their uptake by rat Peyer’s patches following oral administration. Pharm Res 10:1228–31
   PubMed Web of Science ®Google Scholar
• Beg S, Samad A, Nazish I, et al. (2013). Colloidal drug delivery systems in vaccine delivery. Curr Drug Targets 14:123–37
   PubMed Web of Science ®Google Scholar
• Boyd BJ. (2008). Past and future evolution in colloidal drug delivery systems. Expert Opin Drug Deliv 5:69–85
   PubMed Web of Science ®Google Scholar
• Bragagni M, Mennini N, Maestrelli F, et al. (2012). Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Deliv 19:354–61
   PubMed Web of Science ®Google Scholar
• Bramwell VW, Perrie Y. (2006). Particulate delivery systems for vaccines: what can we expect? J Pharm Pharmacol 58:717–28
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Vavia PR. (2005). Nasal drug delivery of sumatriptan succinate. Pharmazie 60:347–9
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu Y, Chen J, et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 376:153–60
   PubMed Web of Science ®Google Scholar
• Chiang CH, Lai JS, Yang KH. (1991). The effect of pH and chemical enhancers on the percutaneous absorption of indomethacin. Drug Dev Ind Pharm 17:91–111
   Web of Science ®Google Scholar
• Conacher M, Alexander J, Brewer JM. (2001). Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine 19:2965–74
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhou R, Liu L, et al. (2013). Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine 8:1921–33
   PubMed Web of Science ®Google Scholar
• Demetzos C, Pippa N. (2014). Advanced drug delivery nanosystems (aDDnSs): a mini-review. Drug Deliv 21:250–7
   PubMed Web of Science ®Google Scholar
• Deneer VH, Drese GB, Roemelé PE, et al. (2002). Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state. Int J Pharm 241:127–34
   PubMed Web of Science ®Google Scholar
• Dertzbaugh MT, Elson CO. (1993). Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect Immun 61:48–55
   PubMed Web of Science ®Google Scholar
• Dial EJ, Rooijakkers SH, Darling RL, et al. (2008). Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes. J Gastroenterol Hepatol 23:430–6
   PubMed Web of Science ®Google Scholar
• Duchateau GSMJE, Zuidema J, Merkus FWHM. (1986). Bile salts and intranasal drug absorption. Int J Pharm 31:193–9
   Web of Science ®Google Scholar
• Eldridge JH, Hammond CJ, Meulbroek JA, et al. (1990). Controlled vaccine release in the gut-associated lymphoid tissues. 1 Orally administered biodegradable microspheres target the Peyer’s patches. J Control Release 11:205–14
   Web of Science ®Google Scholar
• Gangadhar KN, Adhikari K, Srichana T. (2014). Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Int J Pharm 471:430–8
   PubMed Web of Science ®Google Scholar
• Gaspar MM, Martins MB, Corvo ML, Cruz ME. (2003). Design and characterization of enzymosomes with surface-exposed superoxide dismutase. Biochim Biophys Acta 1609:211–17
   PubMed Web of Science ®Google Scholar
• Gaumet M, Gurny R, Delie F. (2009). Localization and quantification of biodegrad-able particles in an intestinal cell model: the influence of particle size. Eur J Pharm Sci 36:465–73
   PubMed Web of Science ®Google Scholar
• Gebril AM, Lamprou DA, Alsaadi MM, et al. (2014). Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles. Nanomedicine 10:971–9
   PubMed Web of Science ®Google Scholar
• Guan P, Lu Y, Qi J, et al. (2011). Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine 6:965–74
   PubMed Web of Science ®Google Scholar
• Guo J, Wu T, Ping Q, et al. (2005). Solubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine A. Drug Deliv 12:35–9
   PubMed Web of Science ®Google Scholar
• Gupta S, Jain A, Chakraborty M, et al. (2013). Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv 20:237–46
   PubMed Web of Science ®Google Scholar
• Henriksen-Lacey M, Perrie Y. (2013). Designing liposomes as vaccine adjuvants. In: Flower DR, Perrie Y, eds. Immunomic discovery of adjuvants and candidate subunit vaccines. New York: Springer, Chapter 10, 181–203
   Google Scholar
• Hofmann AF, Hagey LR. (2008). Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci 65:2461–83
   PubMed Web of Science ®Google Scholar
• Holm R, Müllertz A, Mu H. (2013). Bile salts and their importance for drug absorption. Int J Pharm 453:44–55
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2:67–74
   PubMedGoogle Scholar
• Hu S, Niu M, Hu F, et al. (2013). Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Int J Pharm 441:693–700
   Google Scholar
• Immordino ML, Dosio F, Cattel L. (2006). Stealth liposomes: review of the basic science, rationale, and clinicl applications, existing and potential. Int J Nanomedicine 1:297–315
   PubMed Web of Science ®Google Scholar
• Jain S, Harde H, Indulkar A, Agrawal AK. (2014a). Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. Nanomedicine 10:431–40
   PubMed Web of Science ®Google Scholar
• Jain S, Indulkar A, Harde H, Agrawal AK. (2014b). Oral mucosal immunization using glucomannosylated bilosomes. J Biomed Nanotechnol 10:932–47
   PubMed Web of Science ®Google Scholar
• Jain S, Khomane K, K Jain A, Dani P. (2011). Nanocarriers for transmucosal vaccine delivery. Curr Nanoscience 7:160–77
   Web of Science ®Google Scholar
• Kowapradit J, Apirakaramwong A, Ngawhirunpat T, et al. (2012). Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Eur J Pharm Sci 47:359–66
   PubMed Web of Science ®Google Scholar
• Le Dévédec F, Strandman S, Hildgen P, et al. (2013). PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole. Mol Pharm 10:3057–66
   PubMed Web of Science ®Google Scholar
• Li P, Nielsen HM, Müllertz A. (2012). Oral delivery of peptides and proteins using lipid-based drug delivery systems. Expert Opin Drug Deliv 9:1289–304
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. (2007). Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 340:153–62
   PubMed Web of Science ®Google Scholar
• Mahalingam R, Ravivarapu H, Redkar S, et al. (2007). Transbuccal delivery of 5-aza-2 -deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation. AAPS PharmSciTech 13;8:E55
   Google Scholar
• Malik DK, Baboota S, Ahuja A, et al. (2007). Recent advances in protein and peptide drug delivery systems. Curr Drug Deliv 4:141–51
   PubMedGoogle Scholar
• Mann JF, Scales HE, Shakir E, et al. (2006). Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity. Methods 38:90–5
   PubMed Web of Science ®Google Scholar
• Mann JF, Shakir E, Carter KC, et al. (2009). Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine 27:3643–9
   PubMed Web of Science ®Google Scholar
• Martin SR, Schilstra MJ. (2008). Circular dichroism and its application to the study of biomolecules. Methods Cell Biol 84:263–93
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. (2007). Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles. Int J Nanomedicine 2:595–607
   PubMed Web of Science ®Google Scholar
• McGhee JR, Mestecky J, Dertzbaugh MT, et al. (1992). The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75–88
   PubMed Web of Science ®Google Scholar
• Mikov M, Fawcett JP, Kuhajda K, Kevresan S. (2006). Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents. Eur J Drug Metab Pharmacokinet 31:237–51
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Yamahira T, Nadai T. (1981). Effect of bile flow on indomethacin absorption in rats. Acta Pharm Suec 18:135–8
   PubMedGoogle Scholar
• Morimoto K, Nakai T, Morisaka K. (1987). Evaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in vitro. J Pharm Pharmacol 39:124–6
   PubMed Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. (2006). Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148–58
   PubMed Web of Science ®Google Scholar
• Nguyen S, Alund SJ, Hiorth M, et al. (2011). Studies on pectin coating of liposomes for drug delivery. Colloids Surf B Biointerfaces 88:664–73
   PubMed Web of Science ®Google Scholar
• Nightingale CH, Axelson JE, Gibaldi M. (1971). Physiologic surface-active agents and drug absorption. 8. Effect of bile flow on sulfadiazine absorption in the rat. J Pharm Sci 60:145–7
   PubMed Web of Science ®Google Scholar
• Niu M, Lu Y, Hovgaard L, et al. (2012). Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Eur J Pharm Biopharm 81:265–72
   PubMed Web of Science ®Google Scholar
• Niu M, Lu Y, Hovgaard L, Wu W. (2011). Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomedicine 6:1155–66
   PubMed Web of Science ®Google Scholar
• Niu M, Tan Y, Guan P, et al. (2014). Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int J Pharm 460:119–30
   PubMed Web of Science ®Google Scholar
• Ogiso T, Iwaki M, Yoneda I, et al. (1991). Percutaneous absorption of elcatonin and hypocalcemic effect in rat. Chem Pharm Bull 39:449–53
   PubMed Web of Science ®Google Scholar
• O'Reilly JR, Corrigan OI, O'Driscoll CM. (1994). The effect of mixed micellar systems, bile salt/fatty acids, on the solubility and intestinal absorption of clofazimine (B663) in the anaesthetised rat. Int J Pharm 109:147–54
   Web of Science ®Google Scholar
• Parmentier J, Thewes B, Gropp F, Fricker G. (2011). Oral peptide delivery by tetraether lipid liposomes. Int J Pharm 415:150–7
   PubMed Web of Science ®Google Scholar
• Pandey V, Golhani D, Shukla R. (2014). Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv. [Epub ahead of print]
   Google Scholar
• Premanand B, Prabakaran M, Kiener TK, Kwang J. (2013). Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS One 8:e55536
   PubMed Web of Science ®Google Scholar
• Pütz G, Schmider W, Nitschke R, et al. (2005). Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytes. J Lipid Res 46:2325–38
   PubMed Web of Science ®Google Scholar
• Rath A, Glibowicka M, Nadeau VG, et al. (2009). Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci USA 106:1760–5
   PubMed Web of Science ®Google Scholar
• Saettone MF, Chetoni P, Cerbai R, et al. (1996). Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity. Int J Pharm 142:103–13
   Web of Science ®Google Scholar
• Sahdev P, Ochyl LJ, Moon JJ. (2014). Biomaterials for nanoparticle vaccine delivery systems. Pharm Res 31:2563–82
   Google Scholar
• Samstein RM, Perica K, Balderrama F, et al. (2008). The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials 29:703–8
   PubMed Web of Science ®Google Scholar
• Schubert R, Jaroni H, Schoelmerich J, Schmidt KH. (1983). Studies on the mechanism of bile salt-induced liposomal membrane damage. Digestion 28:181–90
   PubMed Web of Science ®Google Scholar
• Semalty A, Semalty M, Rawat BS, et al. (2009). Pharmacosomes: the lipid-based new drug delivery system. Expert Opin Drug Deliv 6:599–612
   PubMed Web of Science ®Google Scholar
• Shao Z, Mitra AK. (1994). Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs. Pharm Res 11:243–50
   PubMed Web of Science ®Google Scholar
• Shukla A, Katare OP, Singh B, Vyas SP. (2010a). M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm 385:47–52
   PubMed Web of Science ®Google Scholar
• Shukla A, Bhatia A, Amarji B, et al. (2010b). Nano-bilosomes as potential vaccine delivery system for effective combined oral immunization against tetanus and hepatitis B. J Biotech 150:98–9
   Web of Science ®Google Scholar
• Shukla A, Khatri K, Gupta PN, et al. (2008). Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci 11:59–66
   PubMed Web of Science ®Google Scholar
• Shukla A, Singh B, Katare OP. (2011). Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes. Br J Pharmacol 164:820–7
   PubMed Web of Science ®Google Scholar
• Singh P, Prabakaran D, Jain S, et al. (2004). Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm 278:379–90
   PubMed Web of Science ®Google Scholar
• Sinico C, Fadda AM. (2009). Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 6:813–25
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. (2005). Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release 106:298–308
   PubMed Web of Science ®Google Scholar
• Subuddhi U, Mishra AK. (2007). Effect of sodium deoxycholate and sodium cholate on DPPC vesicles: a fluorescence anisotropy study with diphenylhexatriene. J Chem Sci 119:169–74
   Web of Science ®Google Scholar
• Sun J, Deng Y, Wang S, et al. (2010). Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation. Drug Deliv 17:164–70
   PubMed Web of Science ®Google Scholar
• Sun W, Zou W, Huang G, et al. (2008). Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target 16:357–65
   PubMed Web of Science ®Google Scholar
• Tengamnuay P, Mitra AK. (1990). Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa. Pharm Res 7:370–5
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Amiji MM. (2006). Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 6:3215–21
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Gajbhiye V, Sharma R, Jain NK. (2010). Carrier mediated protein and peptide stabilization. Drug Deliv 17:605–16
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60
   PubMed Web of Science ®Google Scholar
• Vyas SP, Subhedar R, Jain S. (2006). Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol 58:321–6
   PubMed Web of Science ®Google Scholar
• Ward PD, Tippin TK, Thakker DR. (2000). Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm Sci Technol Today 3:346–58
   PubMedGoogle Scholar
• Westergaard H. (1977). Duodenal bile acid concentrations in fat malabsorption syndromes. Scand J Gastroent 12:115–22
   PubMed Web of Science ®Google Scholar
• Wilkhu JS, McNeil SE, Anderson DE, Perrie Y. (2013). Characterization and optimization of bilosomes for oral vaccine delivery. J Drug Target 21:291–9
   Google Scholar
• Yu JN, Zhu Y, Wang L, et al. (2010). Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin 31:759–64
   PubMed Web of Science ®Google Scholar
• Zeng X, Tao W, Mei L, et al. (2013). Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 34:6058–67
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gao F, Jiang S, et al. (2013). Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats. Int J Pharm 452:374–81
   PubMed Web of Science ®Google Scholar